Identification of a coagulation-related signature correlated with immune infiltration and their prognostic implications in lung adenocarcinoma

被引:3
作者
Yang, Siqian [1 ,2 ,3 ]
Chen, Shiqi [1 ,2 ,4 ,5 ]
Zhao, Yue [1 ,2 ,4 ,5 ]
Wu, Tao [6 ]
Wang, Yuquan [1 ,2 ,3 ]
Li, Tingting [1 ,2 ,3 ]
Fu, Liwan [7 ]
Ye, Ting [1 ,2 ,4 ,5 ]
Hu, Yue-Qing [1 ,2 ,3 ,8 ]
Chen, Haiquan [1 ,2 ,3 ,4 ,5 ]
机构
[1] Fudan Univ, Dept Thorac Surg, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China
[2] Fudan Univ, State Key Lab Genet Engn, Shanghai Canc Ctr, 270 Dongan Rd, Shanghai 200032, Peoples R China
[3] Fudan Univ, Inst Biostat, Human Phenome Inst, Sch Life Sci, 2005 Songhu Rd, Shanghai 200438, Peoples R China
[4] Fudan Univ, Inst Thorac Oncol, Shanghai, Peoples R China
[5] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China
[6] Shanghai Jiao Tong Univ, Sheng Yushou Ctr Cell Biol & Immunol, Sch Life Sci & Biotechnol, Joint Int Res Lab Metab & Dev Sci, Shanghai, Peoples R China
[7] Capital Med Univ, Beijing Childrens Hosp, Dept Ctr Noncommunicable Dis Management, Beijing, Peoples R China
[8] Fudan Univ, Shanghai Ctr Math Sci, Shanghai, Peoples R China
关键词
coagulation-related genes; immune infiltration; immunotherapy; lung adenocarcinoma; prognosis; CANCER; FIBRINOLYSIS; ACTIVATION; MECHANISMS; EXPRESSION;
D O I
10.1111/1759-7714.15121
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundLung adenocarcinoma (LUAD) is a fatal form of lung cancer with a poor prognosis. Coagulation system had been confirmed closely related to tumor progression and the hypercoagulable state encouraged the immune infiltration and development of tumor cells, leading to a poor prognosis in cancer patients. However, the use of the coagulation-related genes (CRGs) for prognosis in LUAD has yet to be determined. In this study, we constructed an immune-related signature (CRRS) and identified a potential coagulation-related biomarker (P2RX1).MethodsWe obtained a total of 209 CRGs based on two coagulation-related KEGG pathways, then developed the CRRS signature by using the TCGA-LUAD RNA-seq data via the procedure of LASSO-Cox regression, stepwise-Cox regression, univariate and multivariate Cox regression. Grouped by the CRRS, Kaplan-Meier survival curves and receiver operating characteristic curves were drawn for the training and validation sets, respectively. In addition, single-sample gene set enrichment analysis was exploited to explore immune infiltration level. Moreover, immunophenotypes and immunotherapy grouped by CRRS were further analyzed.ResultsWe developed an immune-related signature (CRRS) composed of COL1A2, F2, PLAUR, C4BPA, and P2RX1 in LUAD. CRRS was an independent risk factor for overall survival and displayed stable and powerful performance. Additionally, CRRS possessed distinctly superior accuracy than traditional clinical variables and molecular features. Functional analysis indicated that the differentially high expressed genes in the low-risk group significantly enriched in T cell and B cell receptor signaling pathways. The low-risk group was sensitive to anti-PD-1/PD-L1 immunotherapy and displayed abundant immune infiltration and immune checkpoint gene expression. Finally, we identified an independent prognostic gene P2RX1. Low expression of P2RX1 associated with poor overall survival and decreased immune infiltration.ConclusionsOur study revealed a significant correlation between CRRS and immune infiltration. CRRS could serve as a promising tool to improve the clinical outcomes for individual LUAD patients. image
引用
收藏
页码:3295 / 3308
页数:14
相关论文
共 48 条
  • [1] Lung Cancer 2020 Epidemiology, Etiology, and Prevention
    Bade, Brett C.
    Dela Cruz, Charles S.
    [J]. CLINICS IN CHEST MEDICINE, 2020, 41 (01) : 1 - +
  • [2] Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
    Barbie, David A.
    Tamayo, Pablo
    Boehm, Jesse S.
    Kim, So Young
    Moody, Susan E.
    Dunn, Ian F.
    Schinzel, Anna C.
    Sandy, Peter
    Meylan, Etienne
    Scholl, Claudia
    Froehling, Stefan
    Chan, Edmond M.
    Sos, Martin L.
    Michel, Kathrin
    Mermel, Craig
    Silver, Serena J.
    Weir, Barbara A.
    Reiling, Jan H.
    Sheng, Qing
    Gupta, Piyush B.
    Wadlow, Raymond C.
    Le, Hanh
    Hoersch, Sebastian
    Wittner, Ben S.
    Ramaswamy, Sridhar
    Livingston, David M.
    Sabatini, David M.
    Meyerson, Matthew
    Thomas, Roman K.
    Lander, Eric S.
    Mesirov, Jill P.
    Root, David E.
    Gilliland, D. Gary
    Jacks, Tyler
    Hahn, William C.
    [J]. NATURE, 2009, 462 (7269) : 108 - U122
  • [3] Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
    Becht, Etienne
    Giraldo, Nicolas A.
    Lacroix, Laetitia
    Buttard, Benedicte
    Elarouci, Nabila
    Petitprez, Florent
    Selves, Janick
    Laurent-Puig, Pierre
    Sautes-Fridman, Catherine
    Fridman, Wolf H.
    de Reynies, Aurelien
    [J]. GENOME BIOLOGY, 2016, 17
  • [4] BRUGAROLAS A, 1973, Journal of Surgical Oncology, V5, P359, DOI 10.1002/jso.2930050411
  • [5] IN-VIVO DEPLETION OF CD8+ T-CELLS RESULTS IN TH2 CYTOKINE PRODUCTION AND ALTERNATE MECHANISMS OF ALLOGRAFT-REJECTION
    CHAN, SY
    DEBRUYNE, LA
    GOODMAN, RE
    EICHWALD, EJ
    BISHOP, DK
    [J]. TRANSPLANTATION, 1995, 59 (08) : 1155 - 1161
  • [6] Genomic and immune profiling of pre-invasive lung adenocarcinoma
    Chen, Haiquan
    Carrot-Zhang, Jian
    Zhao, Yue
    Hu, Haichuan
    Freeman, Samuel S.
    Yu, Su
    Ha, Gavin
    Taylor, Alison M.
    Berger, Ashton C.
    Westlake, Lindsay
    Zheng, Yuanting
    Zhang, Jiyang
    Ramachandran, Aruna
    Zheng, Qiang
    Pan, Yunjian
    Zheng, Difan
    Zheng, Shanbo
    Cheng, Chao
    Kuang, Muyu
    Zhou, Xiaoyan
    Zhang, Yang
    Li, Hang
    Ye, Ting
    Ma, Yuan
    Gao, Zhendong
    Tao, Xiaoting
    Han, Han
    Shang, Jun
    Yu, Ying
    Bao, Ding
    Huang, Yechao
    Li, Xiangnan
    Zhang, Yawei
    Xiang, Jiaqing
    Sun, Yihua
    Li, Yuan
    Cherniack, Andrew D.
    Campbell, Joshua D.
    Shi, Leming
    Meyerson, Matthew
    [J]. NATURE COMMUNICATIONS, 2019, 10 (1)
  • [7] Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer
    Date, K.
    Ettelaie, C.
    Maraveyas, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2017, 15 (12) : 2289 - 2299
  • [8] Cross Talk Pathways Between Coagulation and Inflammation
    Foley, Jonathan H.
    Conway, Edward M.
    [J]. CIRCULATION RESEARCH, 2016, 118 (09) : 1392 - 1408
  • [9] The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
    Frafjord, Astri
    Buer, Linn
    Hammarstrom, Clara
    Aamodt, Henrik
    Woldbaek, Per Reidar
    Brustugun, Odd Terje
    Helland, Aslaug
    Oynebraten, Inger
    Corthay, Alexandre
    [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [10] Coagulome and the tumor microenvironment: an actionable interplay
    Galmiche, Antoine
    Rak, Janusz
    Roumenina, Lubka T.
    Saidak, Zuzana
    [J]. TRENDS IN CANCER, 2022, 8 (05): : 369 - 383